SCHEMBL3849321

SCHEMBL3849321

CS(=O)(=O)c1cnc(-c2ncnc3ccc(-c4c[nH]nc4-c4ccc(F)cc4)cc23)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 9/20 0.38
PIK3CA P42336 2/20 0.36
MTOR P42345 1/20 0.36
LMNA P02545 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
HPGD P15428 2/20 0.35
MAPK1 P28482 2/20 0.35
CYP2C19 P33261 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
HIF1A Q16665 1/20 0.35
LOXL2 Q9Y4K0 2/20 0.34
MAP4K4 O95819 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3844989 0.88 MAP4K4 (0.34) KITPIK3CAMTORLMNACYP1A2
SCHEMBL3846459 0.86 KIT (0.37) KITMAP4K4EGFR
SCHEMBL4715276 0.86 KIT (0.38) KITPIK3CAMTORLMNACYP1A2
Hydrochloric Acid SCHEMBL3854735 0.85 KIT (0.38) KITPIK3CAMTORLMNACYP1A2
Hydrochloric Acid SCHEMBL3849425 0.82 KIT (0.53) KITPTGS2
Hydrochloric Acid SCHEMBL3845947 0.82 KIT (0.53) KITPTGS2
Hydrochloric Acid SCHEMBL3849344 0.80 MAP4K4 (0.46) KITPIK3CAMTORLMNACYP1A2
SCHEMBL3846001 0.79 KIT (0.36) KITPIK3CAMTORLMNACYP1A2
SCHEMBL3845843 0.79 PTGS2 (0.35) KITPIK3CAMTORLMNACYP1A2
SCHEMBL3849675 0.79 PIK3CA (0.38) KITPIK3CAMTORLMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed